Drug Store News

View more issues:

Articles in March 4, 2002 issue of Drug Store News

• Slim Fast gets new look, focuses on snack replacement
  by Michael Johnsen
• Duane Reade urban prowess helps chain rebound from 9/11
  by Antoinette Alexander
• ChainDrugStore.net streamlines supplier, retailer communications
• FDA gives clearance to Eisai/Janssen to expand Aciphex indication
  by James Frederick
• Alpharma unit joins roster of generic Ritalin makers
• Bic
• Traditional greeting cards are not folding to online cards
  by Rob Eder
• Dr Pepper Spider-Man sweepstakes, marketing campaign to hit stores
• Eckerd conversion program on track
  by Mike Troy
• Shoppers outlines 2002 growth targets
  by Michael Johnsen
• Walgreens, states seal plan to curb tobacco sales to minors
• Merck-Medco sampling ups generic script counts
• Prism acquires TechRx unit
• Three-blade shaving drives category
  by Liz Parks
• Procter & Gamble
• Cindy Crawford to promote Diet Pepsi
• Rite Aid's Miller disputes Moody's downgrade
  by Michael Johnsen
• Evista gets cardiac OK in JAMA
  by James Frederick
• Drug chains entice teen shoppers with high-turn displays and promos
  by Liz Parks
• Teva appoints Makov to succeed Hurvitz as CEO
• HMO group names health policy planner
• Unilever
• SHOPA survey reveals that consumers go back to basics
  by Antoinette Alexander
• Land O'Lakes to consolidate, cut jobs
• Is Phar-Mor next on Snyder's target list?
  by James Frederick
• Increase in Medicap's Rx sales is yielding continued growth
• Longs' pharmacy sales roll ahead, front-end lagging
• NCPA moves to curb PBM influence
  by James Frederick
• BJ's selects pharmacy system
• Infomercial to shelf: Depilatories sales soar
• Gillette
• Travel Smart
• Eckerd, AHBAI donate funds to the UNCF
• Zellers reconfigures assortment to add one-stop-shopping appeal
  by Mike Duff
• Generic BuSpar clears last hurdle; BMS patent claims found 'baseless.'
  by James Frederick
• It's about time Drug Emporium, Phar-Mor hook up
  by Mark Tosh
• Mutual Pharmaceuticals adds generic Prozac to portfolio
• Record number attends ASAP show
• Avon
• Colgate
• Kmart owes Sara Lee $40 million
• Simon to bid au revoir to CACDS
  by Rob Eder
• Bush card not enough, says AARP
  by James Frederick
• Why aren't city kids a merchandising priority?
  by Rob Eder
• Barr gets OK to launch generic ADD drug
• FMI show to focus on legislation
• Tactica
• Demand for whiter teeth transcends cost, age limits
• ConAgra recalls 36,000 cases of soup
• Brooks changing of the guard commencing at 80 Osco stores
• Duane Reade has appointed former Target executive Kenneth Woodrow to its board
• Schering-Plough's Clarinex receives more allergy indications
  by James Frederick
• Are generic drugs the cure to Medicare's ills?
  by Diane West
• First aid moves past scraped knees
  by Michael Johnsen
• Igo Home Products
• Shaw's ups ante on private label with new Signature brand
• Retailers view Revlon changes as positive
  by Liz Parks
• Harris Teeter rolls out pharmacies
• Pamida, a subsidiary of ShopKo Stores, has given Robert Hafner, its senior vice president of marketing
• 2003 Ad
  by James Frederick
• Central fill increasingly pushes productivity envelope
  by Mark Tosh
• Remington Health Products
• Woodbridge Labs
• Rayovac
• Link Snacks
• Albertson's opens Omaha combo
• ShopKo senior buyer Roger Grueneberg has left the company to join supplier Bausch & Lomb
• King Pharmaceuticals becomes only company to launch Tigan in U.S
  by James Frederick
• Branded drug companies' future pain spells big gains for generic drug makers
  by Diane West
• Bayer
• Church & Dwight
• Staedtler
• Coca-Cola
• Hy-Vee names Jurgens president
• Meijer, which operates 152 supercenters, has restructured its leadership team and appointed co-chairman Hank Meijer as chief executive officer
• Novartis Care Card offers discounts on ophthalmic drugs
  by James Frederick
• GPhA, IGA meetings set for Florida in April
• Novartis
• Del Labs
• Sakura of America

• 1
• 2